Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson's disease

被引:48
|
作者
Rekha, Karamkolly R. [1 ]
Selvakumar, Govindasamy P. [2 ]
机构
[1] Annamalai Univ, Raja Muthaiah Med Coll, Fac Med, Div Biochem, Annamalainagar 608002, Tamil Nadu, India
[2] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India
关键词
Parkinson's disease; MPTP; Geraniol; Neuroprotective; Apoptosis; DOPAMINERGIC-NEURONS; APOPTOTIC DEATH; MOLECULAR PATHWAYS; OXIDATIVE STRESS; MOUSE MODEL; MPTP; NEUROTOXICITY; MITOCHONDRIA; ANTIOXIDANT; ACTIVATION;
D O I
10.1016/j.cbi.2014.04.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a common disabling movement disorder owing to progressive depletion of dopamine in nigrostriatal region, and can be experimentally accelerated by the neurotoxin 1-methyl4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). MPTP-treated mice are a representative animal model for searching for the therapeutic agents for PD without adverse effect. In this study we investigated the effect of geraniol (GE) on chronic MPTP/probenecid (MPTP/p) induced apoptotic changes in nigrostriatal region. We observed that chronic exposure to MPTP/p led to increased expression of apoptotic markers, results in neurodegeneration and motor behavioral impairments in mice. Pretreatment with GE to MPTP/p significantly improved motor functions and ameliorated striatal antioxidant balance. In addition, GE attenuated the expression of apoptotic markers evident by the normalized Bcl-2/Bax ratio and decreased expression of cytochrome-C and caspase-9 in the substantia nigra and striatum of MPTP/p induced mice model of PD. The findings of the present study suggested that GE, a new therapeutic potential avenue may have beneficial effects in slowing or preventing the progression of PD and other neurodegenerative disorders. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 43 条
  • [21] Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice
    Chen, JYR
    Hsu, PC
    Hsu, IL
    Yeh, GC
    NEUROSCIENCE LETTERS, 2001, 314 (1-2) : 49 - 52
  • [22] Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson's Disease
    Prediger, Rui D. S.
    Aguiar, Aderbal S., Jr.
    Rojas-Mayorquin, Argelia Esperanza
    Figueiredo, Claudia P.
    Matheus, Filipe C.
    Ginestet, Laure
    Chevarin, Caroline
    Del Bel, Elaine
    Mongeau, Raymond
    Hamon, Michel
    Lanfumey, Laurence
    Raisman-Vozari, Rita
    NEUROTOXICITY RESEARCH, 2010, 17 (02) : 114 - 129
  • [23] Expression of Cytochrome P450 2A5 in a C57BL/6J Mouse Model of Nonalcoholic Fatty Liver Disease
    Li, Rui
    Guo, Guifang
    Cao, Yuzhen
    Wang, Yuanyuan
    Liu, Fangping
    Zhang, Xiuying
    PHARMACOLOGY, 2013, 92 (1-2) : 26 - 31
  • [24] Prediabetic changes in gene expression induced by aspartame and monosodium glutamate in Trans fat-fed C57Bl/6 J mice
    Collison, Kate S.
    Makhoul, Nadine J.
    Zaidi, Marya Z.
    Inglis, Angela
    Andres, Bernard L.
    Ubungen, Rosario
    Saleh, Soad
    Al-Mohanna, Futwan A.
    NUTRITION & METABOLISM, 2013, 10
  • [25] L-Ergothioneine ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in C57BL/6J mice by activating DJ-1
    Meng, Xianshe
    Meng, Huawen
    Hou, Shuzeng
    Yin, Zequn
    Wang, Xuerui
    Gong, Ke
    Zhang, Feng
    Li, Qingshan
    Zhang, Shuang
    Chen, Yuanli
    Yang, Xiaoxiao
    Zhao, Zhiwei
    Liao, Chenzhong
    Duan, Yajun
    FOOD SCIENCE AND HUMAN WELLNESS, 2025, 14 (03)
  • [26] Study of BDE-47 induced Parkinson's disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis
    Ji, Fenfen
    Sreenivasmurthy, Sravan Gopalkrishnashetty
    Wei, Juntong
    Shao, Xiaojian
    Luan, Hemi
    Zhu, Lin
    Song, Juxian
    Liu, Liangfeng
    Li, Min
    Cai, Zongwei
    JOURNAL OF HAZARDOUS MATERIALS, 2019, 378
  • [27] Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
    Rui D. S. Prediger
    Aderbal S. Aguiar
    Argelia Esperanza Rojas-Mayorquin
    Claudia P. Figueiredo
    Filipe C. Matheus
    Laure Ginestet
    Caroline Chevarin
    Elaine Del Bel
    Raymond Mongeau
    Michel Hamon
    Laurence Lanfumey
    Rita Raisman-Vozari
    Neurotoxicity Research, 2010, 17 : 114 - 129
  • [28] Effect of interferon on the development of parkinsonism induced by the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrine (MPTP) in C57Bl/6 mice
    Davydova, TV
    Fomina, VG
    Kryzhanovskii, GN
    Krupina, NA
    Pletsityi, KD
    Kucheryanu, VG
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1996, 121 (05) : 456 - 458
  • [29] Protective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson's Disease-Like Symptoms in C57BL/6 Mouse
    Singsai, Kanathip
    Akaravichien, Tarinee
    Kukongviriyapan, Veerapol
    Sattayasai, Jintana
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [30] Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in Aβ1-42 induced C57BL/6 mice for Alzheimer's disease treatment
    Prabakaran, A.
    Rakshit, Debarati
    Patel, Inklisan
    Susanna, K. Jony
    Mishra, Awanish
    Radhakrishnanand, P.
    Sarma, Phulen
    Alexander, Amit
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 305